Calcitriol Supplementation in COVID-19 Patients

NCT05415254 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2022-06-13

No results posted yet for this study

Summary

This is a randomized, open label study to evaluate the efficacy and safety of calcitriol supplementation in COVID-19 patients with vitamin D deficiency.

Conditions

Interventions

DRUG

Calcitriol

Calcitriol supplementation orally

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Jing Ma, Dr. · RenJi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-12
Primary Completion
2022-08-19
Completion
2022-09-19

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05415254 on ClinicalTrials.gov